These findings suggest that the simultaneous enrichment of CCL18-producing macrophages and the suppression of MAPK10 activity can create an immune-infiltrated yet functionally suppressed tumor microenvironment, explaining the paradoxical association between immune cell presence and poor clinical outcome observed in ABC DLBCL. The gene discussed is CCL18; the disease is diffuse large B-cell lymphoma.